Riyadh biotech summit to draw 15,000 visitors in September

Saudi Arabia’s Riyadh Global Medical Biotechnology Summit returns Sept. 14-16 with more than 100 speakers, delegations from over 70 countries and a target of more than 65 deals and MoUs. The event is designed to advance the kingdom’s biotechnology strategy, which aims to generate $34.6 billion in non-oil GDP by 2040.

Why it matters: - Saudi Arabia is using the summit to showcase the infrastructure, talent and investment base behind its national biotechnology strategy. - The event is tied to a long-term economic goal: $34.6 billion in non-oil GDP from biotechnology by 2040. - The summit is meant to connect discovery research, manufacturing, regulation and commercialization in one place.

What happened: - The Riyadh Global Medical Biotechnology Summit 2026 will take place in Riyadh from Sept. 14-16. - The fourth edition is expected to draw more than 15,000 visitors. - More than 100 local and international speakers are scheduled. - Organizers expect 200 biotechnology and healthcare brands and more than 80 exhibiting entities from government and industry. - Delegations from more than 70 countries are expected to attend. - Organizers are targeting more than 65 agreements and memoranda of understanding over the three-day event.

The details: - The scientific program covers six tracks: artificial intelligence in biotechnology, multi-omics and localization, biotech investment, immunology, bioengineering and synthetic biology, and biotech workforce development. - The agenda follows the biomedical innovation pipeline from population-scale genomics and AI-enabled drug discovery to domestic biomanufacturing, regulatory science, commercialization and investment. - The summit is organized under the supervision of the Ministry of National Guard, through its Health Affairs sector. - King Abdullah International Medical Research Center and King Saud bin Abdulaziz University for Health Sciences are hosting the event. - The Ministry of Investment, Invest Saudi and the Saudi Data & AI Authority are serving as strategic partners. - Registration is open for delegates, exhibitors and industry partners. - The full scientific program, speaker lineup and event information are available here. - Summit updates will be shared under #RGMBS2026.

Between the lines: - The summit theme, “Building the Foundations of Biotechnology Excellence,” signals a shift from broad international visibility to building the scientific and industrial systems needed for scale. - H.E. Prof. Bandar Alknawy said the foundations include advanced laboratories, integrated research centers, clinical trial networks, biomanufacturing capabilities and digital platforms. - Prof. Alknawy also highlighted national talent development and leadership across academia, industry and regulation as required for a resilient biotech ecosystem. - Saudi Arabia is using global partnerships to reinforce that effort, including collaborations with Harvard University in translational oncology, AstraZeneca in gene therapy and Peking University in drug discovery. - The structure of the program suggests the summit is being used as both a policy platform and a deal-making venue.

What's next: - Delegates, exhibitors and industry partners can register now. - The event is expected to produce new agreements, research connections and investment discussions during the Sept. 14-16 summit. - Organizers will use the summit to show international visitors the country’s regulatory frameworks, manufacturing infrastructure and translational research capacity. - Future editions will likely be judged by how well Saudi Arabia converts summit attention into biotech investment, local capability and commercial output.

The bottom line: - RGMBS 2026 is designed to be more than a conference. It is a showcase for Saudi Arabia’s effort to build a full biotechnology ecosystem, from discovery to commercial production.